Hudson Bay Capital Management’s Apyx Medical APYX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
– Sell
-54,001
Closed -$199K – 1363
2026
Q1
$199K Buy
54,001
+33,282
+161% +$124K ﹤0.01% 1106
2025
Q4
$72.5K Buy
+20,719
New +$72.3K ﹤0.01% 1056

Other funds holding APYX

Hudson Bay Capital Management's APYX Position: Q2 2026 in Review

Hudson Bay Capital Management sold out of Apyx Medical (APYX) in Q2 2026, closing a stake of 54,001 shares — an estimated $199K sold.

Hudson Bay Capital Management first reported a position in APYX in Q4 2025 and held it in 2 quarters. The position peaked at $199K in Q1 2026. 67 funds tracked by Wall St. Rank hold APYX as of Q2 2026.

  • Hudson Bay Capital Management reported no remaining Apyx Medical position as of Q2 2026 after selling out during the quarter.
  • Hudson Bay Capital Management sold 54,001 Apyx Medical shares in Q2 2026, an estimated $199K.
  • Hudson Bay Capital Management first reported a position in Apyx Medical in Q4 2025 and held it in 2 quarters.
  • Hudson Bay Capital Management's Apyx Medical position peaked at $199K in Q1 2026.
  • 67 funds tracked by Wall St. Rank held Apyx Medical as of Q2 2026.

Based on Hudson Bay Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.